A polymeric prodrug of cisplatin based on pullulan for the targeted therapy against hepatocellular carcinoma.
第一作者:
Yan,Wang
第一单位:
School of Pharmacy, Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics) & Research Center of Basic Medical Science, Tianjin Medical University, No. 22 Qixiangtai Road, Heping District, Tianjin 300070, PR China.
作者:
主题词
动物(Animals);抗肿瘤药(Antineoplastic Agents);癌, 肝细胞(Carcinoma, Hepatocellular);细胞周期(Cell Cycle);细胞增殖(Cell Proliferation);细胞存活(Cell Survival);顺铂(Cisplatin);剂量效应关系, 药物(Dose-Response Relationship, Drug);药物筛选试验, 抗肿瘤(Drug Screening Assays, Antitumor);女(雌)性(Female);Hep G2细胞(Hep G2 Cells);人类(Humans);肝肿瘤(Liver Neoplasms);肝肿瘤, 实验性(Liver Neoplasms, Experimental);小鼠(Mice);小鼠, 近交BALB C(Mice, Inbred BALB C);小鼠, 裸(Mice, Nude);分子结构(Molecular Structure);聚合物(Polymers);药物前体(Prodrugs);构效关系(Structure-Activity Relationship)
DOI
10.1016/j.ijpharm.2015.02.027
PMID
25681730
发布时间
2015-03-09
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文